108 related articles for article (PubMed ID: 9816273)
1. Loss of DCC expression in neuroblastoma is associated with disease dissemination.
Reale MA; Reyes-Mugica M; Pierceall WE; Rubinstein MC; Hedrick L; Cohn SL; Nakagawara A; Brodeur GM; Fearon ER
Clin Cancer Res; 1996 Jul; 2(7):1097-102. PubMed ID: 9816273
[TBL] [Abstract][Full Text] [Related]
2. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
[TBL] [Abstract][Full Text] [Related]
3. Status of deleted in colorectal cancer gene expression correlates with neuroblastoma metastasis.
Reyes-Mugica M; Lin P; Yokota J; Reale MA
Lab Invest; 1998 Jun; 78(6):669-75. PubMed ID: 9645757
[TBL] [Abstract][Full Text] [Related]
4. Expression of a homologue of the deleted in colorectal cancer (DCC) gene in the nervous system of developing Xenopus embryos.
Pierceall WE; Reale MA; Candia AF; Wright CV; Cho KR; Fearon ER
Dev Biol; 1994 Dec; 166(2):654-65. PubMed ID: 7813784
[TBL] [Abstract][Full Text] [Related]
5. DCC genetic alterations and expression in endometrial carcinoma.
Ronnett BM; Burks RT; Cho KR; Hedrick L
Mod Pathol; 1997 Jan; 10(1):38-46. PubMed ID: 9021725
[TBL] [Abstract][Full Text] [Related]
6. The DCC protein and prognosis in colorectal cancer.
Shibata D; Reale MA; Lavin P; Silverman M; Fearon ER; Steele G; Jessup JM; Loda M; Summerhayes IC
N Engl J Med; 1996 Dec; 335(23):1727-32. PubMed ID: 8929264
[TBL] [Abstract][Full Text] [Related]
7. Frequent allelic deletions and loss of expression characterize the DCC gene in male germ cell tumors.
Murty VV; Li RG; Houldsworth J; Bronson DL; Reuter VE; Bosl GJ; Chaganti RS
Oncogene; 1994 Nov; 9(11):3227-31. PubMed ID: 7936646
[TBL] [Abstract][Full Text] [Related]
8. The deleted in colorectal cancer (DCC) gene: a candidate tumour suppressor gene encoding a cell surface protein with similarity to neural cell adhesion molecules.
Fearon ER; Pierceall WE
Cancer Surv; 1995; 24():3-17. PubMed ID: 7553661
[TBL] [Abstract][Full Text] [Related]
9. Loss of DCC expression and glioma progression.
Reyes-Mugica M; Rieger-Christ K; Ohgaki H; Ekstrand BC; Helie M; Kleinman G; Yahanda A; Fearon ER; Kleihues P; Reale MA
Cancer Res; 1997 Feb; 57(3):382-6. PubMed ID: 9012460
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel human neuronal leucine-rich repeat (hNLRR) family genes and inverse association of expression of Nbla10449/hNLRR-1 and Nbla10677/hNLRR-3 with the prognosis of primary neuroblastomas.
Hamano S; Ohira M; Isogai E; Nakada K; Nakagawara A
Int J Oncol; 2004 Jun; 24(6):1457-66. PubMed ID: 15138588
[TBL] [Abstract][Full Text] [Related]
11. Loss of DCC gene expression during ovarian tumorigenesis: relation to tumour differentiation and progression.
Saegusa M; Machida D; Okayasu I
Br J Cancer; 2000 Feb; 82(3):571-8. PubMed ID: 10682668
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of pleiotrophin and midkine in advanced neuroblastomas.
Nakagawara A; Milbrandt J; Muramatsu T; Deuel TF; Zhao H; Cnaan A; Brodeur GM
Cancer Res; 1995 Apr; 55(8):1792-7. PubMed ID: 7712489
[TBL] [Abstract][Full Text] [Related]
13. Interaction of Myc-associated zinc finger protein with DCC, the product of a tumor-suppressor gene, during the neural differentiation of P19 EC cells.
Ugai H; Li HO; Komatsu M; Tsutsui H; Song J; Shiga T; Fearon E; Murata T; Yokoyama KK
Biochem Biophys Res Commun; 2001 Sep; 286(5):1087-97. PubMed ID: 11527412
[TBL] [Abstract][Full Text] [Related]
14. Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers.
Hilgers W; Song JJ; Haye M; Hruban RR; Kern SE; Fearon ER
Genes Chromosomes Cancer; 2000 Apr; 27(4):353-7. PubMed ID: 10719364
[TBL] [Abstract][Full Text] [Related]
15. Altered phenotype of HT29 colonic adenocarcinoma cells following expression of the DCC gene.
Velcich A; Corner G; Palumbo L; Augenlicht L
Oncogene; 1999 Apr; 18(16):2599-606. PubMed ID: 10353603
[TBL] [Abstract][Full Text] [Related]
16. Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma.
Carvalho AL; Chuang A; Jiang WW; Lee J; Begum S; Poeta L; Zhao M; Jerónimo C; Henrique R; Nayak CS; Park HL; Brait MR; Liu C; Zhou S; Koch W; Fazio VM; Ratovitski E; Trink B; Westra W; Sidransky D; Moon CS; Califano JA
Cancer Res; 2006 Oct; 66(19):9401-7. PubMed ID: 17018594
[TBL] [Abstract][Full Text] [Related]
17. Lack of class I HLA expression in neuroblastoma is associated with high N-myc expression and hypomethylation due to loss of the MEMO-1 locus.
Cheng NC; Beitsma M; Chan A; Op den Camp I; Westerveld A; Pronk J; Versteeg R
Oncogene; 1996 Oct; 13(8):1737-44. PubMed ID: 8895520
[TBL] [Abstract][Full Text] [Related]
18. Frequent loss of expression of the potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma.
Höhne MW; Halatsch ME; Kahl GF; Weinel RJ
Cancer Res; 1992 May; 52(9):2616-9. PubMed ID: 1314700
[TBL] [Abstract][Full Text] [Related]
19. Netrin-1: interaction with deleted in colorectal cancer (DCC) and alterations in brain tumors and neuroblastomas.
Meyerhardt JA; Caca K; Eckstrand BC; Hu G; Lengauer C; Banavali S; Look AT; Fearon ER
Cell Growth Differ; 1999 Jan; 10(1):35-42. PubMed ID: 9950216
[TBL] [Abstract][Full Text] [Related]
20. Phenotype of mice lacking functional Deleted in colorectal cancer (Dcc) gene.
Fazeli A; Dickinson SL; Hermiston ML; Tighe RV; Steen RG; Small CG; Stoeckli ET; Keino-Masu K; Masu M; Rayburn H; Simons J; Bronson RT; Gordon JI; Tessier-Lavigne M; Weinberg RA
Nature; 1997 Apr; 386(6627):796-804. PubMed ID: 9126737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
